TARDITO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.459
EU - Europa 893
AS - Asia 227
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 3
SA - Sud America 1
Totale 5.604
Nazione #
US - Stati Uniti d'America 4.399
DE - Germania 226
UA - Ucraina 202
CN - Cina 153
SE - Svezia 125
GB - Regno Unito 87
IE - Irlanda 69
SG - Singapore 58
CA - Canada 56
FI - Finlandia 51
IT - Italia 50
RU - Federazione Russa 47
EU - Europa 21
PL - Polonia 13
FR - Francia 12
IL - Israele 11
BE - Belgio 8
IN - India 3
MX - Messico 3
SC - Seychelles 2
AL - Albania 1
EC - Ecuador 1
EG - Egitto 1
GL - Groenlandia 1
IR - Iran 1
NL - Olanda 1
SI - Slovenia 1
TW - Taiwan 1
Totale 5.604
Città #
Fairfield 791
Chandler 506
Woodbridge 383
Ashburn 336
Seattle 326
Jacksonville 315
Cambridge 285
Houston 281
Wilmington 279
Ann Arbor 156
Beijing 115
Lawrence 70
Princeton 69
Dublin 68
New York 65
Ottawa 56
Helsinki 45
London 39
San Diego 29
Boardman 16
Hefei 15
West Jordan 14
Kraków 13
Kursk 10
Redwood City 10
St Louis 10
Chiswick 9
Prescot 9
Brussels 8
Milan 7
Nanjing 5
Falls Church 4
Guangzhou 4
Brescia 3
Dearborn 3
Islington 3
Mexico City 3
Norwalk 3
Sotto 3
Chicago 2
Hounslow 2
Jinan 2
Kilburn 2
Nanchang 2
New Bedfont 2
Redmond 2
Segrate 2
Berlin 1
Bologna 1
Cairo 1
Calusco D'adda 1
Cascina 1
Cedar Knolls 1
Falkenstein 1
Giussano 1
Greenville 1
Groningen 1
Guiyang 1
Hebei 1
Jinhua 1
Kunming 1
Lappeenranta 1
Ljubljana 1
Los Angeles 1
Mapello 1
Miami Beach 1
New Delhi 1
Nuuk 1
Paris 1
Piacenza 1
Pune 1
Quito 1
Quzhou 1
Ruvo Di Puglia 1
San Giuseppe Vesuviano 1
Santa Clara 1
Secaucus 1
Shanghai 1
Shenyang 1
Taipei 1
Tappahannock 1
Tirana 1
Treviso 1
Wandsworth 1
Washington 1
Wuhan 1
Yoshkar-ola 1
Zhengzhou 1
Zhoushan 1
Totale 4.424
Nome #
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 224
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 188
Physical Exercise and Antidepressants Enhance BDNF Targeting in Hippocampal CA3 Dendrites : Further Evidence of a Spatial Code for BDNF Splice Variants 182
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 161
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 160
Blood microRNA changes in depressed patients during antidepressant treatment 143
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 140
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia 140
Molecular neuroplasticity in mood disorders and drug action: lessons front a gene X environment model 139
Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder 136
Implications of the cAMP signaling pathway in psychiatric disorders: a systematic review of the evidence 131
Expression and phosphorylation of δ-CaM kinase II in cultured Alzheimer fibroblasts 125
Synaptoproteomics of Existing and new Animal Models of Depression 123
Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment 120
Global epigenetic analysis of BDNF Val66Met mice hippocampus reveals changes in dendrite and spine remodeling genes 117
Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus 111
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine 111
Effects of lithium on cAMP-dependent protein kinase in rat brain 104
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 100
Agomelatine and fluoxetine treatments induce different and time-dependent modulation of rat hippocampal miRNome 98
Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants 93
Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants 93
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 91
Early and time-dependent modulation of rat hippocampal miRNome during treatment with agomelatine 90
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 87
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 86
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants : a critical overview 86
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 84
Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression 83
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs 83
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors 80
Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder 80
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression 80
Synergistic mechanisms involved in the antidepressant effects of agomelatine 75
Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells 75
Early induction of CREB activation and CREB-regulating signalling by antidepressants 74
Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades 74
Protein kinase A and Rap1 levels in platelets of untreated patients with major depression 70
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors 66
Synergy between melatonergic and 5-HT2C receptors in the action of agomelatine : molecular and cellular evidence 65
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs 64
Lithium effects on basal and stimulated CREB phosphorylation in SH-SY5Y cells: a bimodal action on CaMKIV and Erk1/2 62
Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder 60
cAMP signaling pathway in depressed patients with psychotic features 60
TIME-DEPENDENT EFFECTS OF ANTIDEPRESSANT TREATMENTS ON MIRNOME EXPRESSION PROFILE IN HIPPOCAMPUS OF RATS 58
Agomelatine Treatment Induces Early and Time- dependent Modulation of Rat Hippocampal MiRNome 58
The interface between depression and cerebrovascular disease--some hope but no hype 57
Biologia dei citocromi P450: caratteristiche generali 55
Depressione, attivazione piastrinica e malattie cardiovascolari 54
Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments 52
Epigenetic analysis reveals selective impairment of bdnf-6 expression and dendritic translocation in BDNF Val66Met transgenic mice 50
Protein kinase A activity in platelets from patients with bipolar disorder 49
Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment 49
Psicofarmacologia clinica 47
Psicofarmacologia clinica 45
Implications of cAMP signaling in affective disorders: new answers more questions 45
Chronic Antidepressants Induce Redistribution and Differential Activation of αCaM Kinase II between Presynaptic Compartments 45
The action of stress on depolarization-evoked release of glutamate and the protective effect of antidepressants 45
Trattamento dei disturbi da uso di sostanze 43
Long-term soluble Aβ1–40 activates CaM kinase II in organotypic hippocampal cultures 43
I citocromi P450. Dalla biologia alla terapia 41
Amisulpride 38
The protein kinase A in platelets from patients with panic disorder 36
[Implications of cAMP signaling in affective disorders] 29
Reboxetina 27
Implicaciones de la señal AMPc en los trastornos afectivos 26
Time in the brain : rythms of intercellular and intracellular processes 26
Inibitori reversibili delle MAO-A (RIMA) 25
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 13
null 10
null 1
Totale 5.681
Categoria #
all - tutte 30.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 22 18
2019/20201.307 8 19 45 133 14 232 169 207 169 193 54 64
2020/20212.067 111 146 294 408 168 283 208 112 100 38 149 50
2021/2022483 69 44 89 56 3 34 26 104 21 21 13 3
2022/20231.301 141 51 39 177 105 269 1 165 227 34 70 22
2023/2024298 18 30 47 40 54 75 9 8 0 17 0 0
Totale 5.681